Table 1.
Characterization of AD tau preparations. Descriptive information related to the cases of AD PHFs tau prepared for these studies. PMI, postmortem interval
Case | Age | Sex | PMI (hours) | Total protein (μg/μL) | Tau (μg/μL) | Tau (%protein) | α-Syn (μg/mL) | Aβ 1–40 (ng/mL) | Aβ 1–42 (ng/mL) |
AD Case 1 | 73 | F | 4 | 8.3 | 2.6 | 31.3 | 0.7 | 31.2 | 111.4 |
AD Case 2 | 62 | M | 12 | 8.7 | 1.4 | 16.1 | 0.5 | 53.7 | 60.1 |